The relation between plasma miR-126 levels and cerebral collateral circulation in patients with intracranial arterial stenosis
Abstract
Objective. This study aimed to investigate the correlation between the circulating miR-126 regulation pathway and the cerebral collateral circulation (CCC), and to test whether miR-126 could serve as a potential biomarker for CCC formation in patients with intracranial arterial stenosis or occlusion.
Material and methods. This single-centre cross-sectional study enrolled patients who underwent cerebral angiography with severe stenosis (≥70%) or occlusion in at least one major intracranial artery. Collateral degree was graded according to the ASITN/SIR classification. The patients were divided into a good CCC group (grade 3–4) or a poor CCC group (grade 0–2). We investigated the plasma levels of miR-126, VEGF, Spred-1 and PIK3R2 by using qRT-PCR, ELISA and Western blot methods, respectively. In addition, we assessed the correlations of plasma miR-126 with VEGF, Spred-1, PIK3R2 and ASITN/SIR grade using the Spearman correlation test and investigated its predictive power for CCC status by using the receiver operating characteristic curve.
Results. A total of 68 patients were enrolled (44 with good CCC and 24 with poor CCC). Data showed that plasma miR-126 and VEGF were significantly higher in the good CCC group than in the poor CCC group. Plasma Spred-1 and PIK3R2 level were lower in the good CCC group than in the poor CCC group. In addition, miR-126 and VEGF were positively correlated with ASITN/SIR (miR-126: R = 0.595, P < 0.01; VEGF: R = 0.595, P < 0.01), whereas Spred-1 and PIK3R2 were negatively correlated with ASITN/SIR (Spred-1: R = -0.817, P < 0.01; PIK3R2: R = -0.513, P=0.01). However, the area under the curve of miR-126 level for CCC status was only 0.328 (95% CI: 0.158–0.498; p = 0.067).
Conclusions. Plasma miR-126 level may be related to better CCC formation, one of the mechanisms that may be explained by upregulation of VEGF and reduction of Spred-1 and PIK3R2 protein expression. However, miR-126 might not be an independent predictor for CCC, given its low predictive value.
Keywords: miR-126VEGFcerebral collateral circulationASITN/SIRbiomarker
References
- Goyal M, Demchuk AM, Menon BK, et al. ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015; 372(11): 1019–1030.
- Sheth SA, Liebeskind DS. "Imaging Evaluation of Collaterals in the Brain: Physiology and Clinical Translation". Curr Radiol Rep. 2014; 2(1): 29.
- Villringer K, Zimny S, Galinovic I, et al. The Association Between Recanalization, Collateral Flow, and Reperfusion in Acute Stroke Patients: A Dynamic Susceptibility Contrast MRI Study. Front Neurol. 2019; 10: 1147.
- Shah VS, Eaton RG, Cua S, et al. Scoring of Middle Cerebral Artery Collaterals Predicts RAPID CT-Perfusion Analysis and Short-Term Outcomes in Acute Ischemic Stroke Patients Undergoing Thrombectomy. World Neurosurg. 2020; 135: e494–e499.
- Leng X, Fang H, Leung TWH, et al. Impact of collaterals on the efficacy and safety of endovascular treatment in acute ischaemic stroke: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2016; 87(5): 537–544.
- Liebeskind DS, Tomsick TA, Foster LD, et al. IMS III Investigators. Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial. Stroke. 2014; 45(3): 759–764.
- Guglielmi V, LeCouffe NE, Zinkstok SM, et al. MR-CLEAN Registry Investigators. Collateral Circulation and Outcome in Atherosclerotic Versus Cardioembolic Cerebral Large Vessel Occlusion. Stroke. 2019; 50(12): 3360–3368.
- Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet. 2011; 12(2): 99–110.
- Nazari-Jahantigh M, Wei Y, Schober A. The role of microRNAs in arterial remodelling. Thromb Haemost. 2012; 107(4): 611–618.
- Welten SMJ, Bastiaansen AJ, de Jong RCM, et al. Inhibition of 14q32 MicroRNAs miR-329, miR-487b, miR-494, and miR-495 increases neovascularization and blood flow recovery after ischemia. Circ Res. 2014; 115(8): 696–708.
- Lagos-Quintana M, Rauhut R, Yalcin A, et al. Identification of tissue-specific microRNAs from mouse. Curr Biol. 2002; 12(9): 735–739.
- Wienholds E, Kloosterman WP, Miska E, et al. MicroRNA expression in zebrafish embryonic development. Science. 2005; 309(5732): 310–311.
- Wang S, Aurora AB, Johnson BA, et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008; 15(2): 261–271.
- Fish JE, Santoro MM, Morton SU, et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell. 2008; 15(2): 272–284.
- Hakimzadeh N, Nossent AY, van der Laan AM, et al. Circulating MicroRNAs Characterizing Patients with Insufficient Coronary Collateral Artery Function. PLoS One. 2015; 10(9): e0137035.
- Nie X, Su L, Zhou Y, et al. [Association between plasma levels of microRNA-126 and coronary collaterals in patients with coronary artery disease]. Zhonghua Xin Xue Guan Bing Za Zhi. 2014; 42(7): 561–565.
- Huang F, Zhu X, Hu XQ, et al. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival. Int J Mol Med. 2013; 31(2): 484–492.
- Hu J, Zeng L, Huang J, et al. miR-126 promotes angiogenesis and attenuates inflammation after contusion spinal cord injury in rats. Brain Res. 2015; 1608: 191–202.
- Ye L, Peng Y, Mo J, et al. MiR-126 enhances VEGF expression in induced pluripotent stem cell-derived retinal neural stem cells by targeting spred-1. Int J Clin Exp Pathol. 2018; 11(2): 1023–1030.
- Meng S, Cao JT, Zhang B, et al. Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J Mol Cell Cardiol. 2012; 53(1): 64–72.
- Ji JS, Xu M, Song JJ, et al. Inhibition of microRNA-126 promotes the expression of Spred1 to inhibit angiogenesis in hepatocellular carcinoma after transcatheter arterial chemoembolization: in vivo study. Onco Targets Ther. 2016; 9: 4357–4367.
- Wang L, Lee AY, Wigg JP, et al. miR-126 Regulation of Angiogenesis in Age-Related Macular Degeneration in CNV Mouse Model. Int J Mol Sci. 2016; 17(6).
- Nie X, Su L, Zhou Y, et al. Association between plasma levels of microRNA-126 and coronary collaterals in patients with coronary artery disease. Zhonghua Xin Xue Guan Bing Za Zhi. 2014; 42(7): 561–565.
- Chistiakov DA, Orekhov AN, Bobryshev YV. The role of miR-126 in embryonic angiogenesis, adult vascular homeostasis, and vascular repair and its alterations in atherosclerotic disease. J Mol Cell Cardiol. 2016; 97: 47–55.
